Physician

Brian G. Fuller, M.D.

According to 2025 Medicare claims, Brian Fuller, M.D. (NPI: 1396834412) practices radiation oncology in the Farmington, NM market, with the plurality of this provider's patient population coming from San Juan, NM. This provider's primary affiliated billing organization is SAN JUAN REGIONAL MEDICAL CENTER INC (NPI: 1699938282; TIN: 850127924) and primary practice location at 87401-5630. Fuller is affiliated with the UC Irvine Health Accountable Care Organization (ACO ID: A3799) and Aledade 99 Pacific Northwest MSSP Enhanced (ACO ID: A4999), participating under the MSSP model.

Fuller's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 124 traditional Medicare patients, billed 1,153 HCPCS/CPT codes, and received $116,299 in Medicare payments. The top billing code was 77427 (Radiation treatment management, 5 treatment sessions). Part D data shows 156 prescription claims across 55 beneficiaries totaling $11,002 in drug costs, led by Dexamethasone (Dexamethasone). 2019 DME data shows 101 claims. Open Payments data shows 2 records totaling $80. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has moved up and down with repeated peaks and valleys, starting at $97,116 and ending at $116,299. Concurrently, Part D prescription costs have moved up and down with repeated peaks and valleys, starting at $2,549 and ending at $11,002. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	172	1,685	$97,116
2016	197	1,800	$114,612
2017	164	1,395	$80,924
2018	205	3,467	$209,041
2019	280	6,205	$328,279
2020	242	4,550	$225,639
2021	20	152	$15,531
2022	67	868	$51,970
2023	112	995	$84,330
2024	124	1,153	$116,299

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	54	111	$2,549
2016	56	144	$3,017
2017	35	77	$1,815
2018	65	181	$5,184
2019	91	244	$6,155
2020	83	316	$4,924
2021	N/R	13	$210
2022	27	69	$25,810
2023	22	44	$15,817
2024	55	156	$11,002

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	61	$29,812
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	11	101	$17,427
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	N/R	N/R
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
77427	Radiation treatment management, 5 treatment sessions	62	246	$144
99205	New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more	71	71	$137
77263	Complex radiation therapy planning	63	69	$128
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	61	94	$50
77300	Calculation of radiation therapy dose	63	251	$25

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Dexamethasone	Dexamethasone	19	329	$229
Tamsulosin Hcl	Tamsulosin Hcl	18	618	$125
Prochlorperazine Maleate	Prochlorperazine Maleate	14	176	$116
Chlorhexidine Gluconate	Chlorhexidine Gluconate	13	204	$56

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	2	$80	Davol Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Brian G. Fuller, M.D.?

Tedicare shows public-source Medicare data for Brian G. Fuller, M.D. (NPI 1396834412), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Brian G. Fuller, M.D. have ACO affiliation data?

Brian G. Fuller, M.D. is shown with ACO affiliation data for UC Irvine Health Accountable Care Organization (MSSP, ACO ID A3799) and Aledade 99 Pacific Northwest MSSP Enhanced (MSSP, ACO ID A4999).

What billing organization is linked to Brian G. Fuller, M.D.?

Brian G. Fuller, M.D. is linked to SAN JUAN REGIONAL MEDICAL CENTER INC (billing NPI 1699938282) in the available physician profile data.

Does Brian G. Fuller, M.D. have Open Payments data?

Brian G. Fuller, M.D. has 2 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.